Tirzepatide and Ozempic (Semaglutide) are both GLP-1 receptor agonists for type 2 diabetes and obesity but they are not the same
La semaglutida se vende bajo las marcas Ozempic (para la diabetes) y Wegovy (para la prdida de peso)
Weekly injections: pick a day and stick with it Most GLP-1 medications like semaglutide and tirzepatide use once-weekly dosing
Arteriosclerosis, thrombosis and vascular biology 22, 12321238 (2002)
These medicines influence immune, metabolic, and neural pathways simultaneously, which positions them as a powerful class of anti-inflammatory agents with far-reaching clinical potential.
More serious but rare risks include pancreatitis, gallbladder disease, and in diabetes patients, potential worsening of diabetic retinopathy (particularly with semaglutide)